Previous Article | Next Article ![]()
Journal of Bacteriology, July 2003, p. 3828-3841, Vol. 185, No. 13
0021-9193/03/$08.00+0 DOI: 10.1128/JB.185.13.3828-3841.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.
Laboratoire de Biochimie et Biophysique des Systèmes Intégrés,1 Laboratoire de Chimie des Protéines, Département de Réponse et Dynamique Cellulaires, CNRS UMR 5092, CEA-Grenoble, F-38054 Grenoble Cedex 9,3 Equipe Perturbations Environnementales et Xénobiotiques, Laboratoire d'Écologie Alpine, UMR CNRS 5553, Université Joseph Fourier-Grenoble 1, BP 53, F-38041 Grenoble Cedex 9, France2
Received 7 March 2003/ Accepted 14 April 2003
|
|
|---|
|
|
|---|
Early studies on the catabolism of pyrene by a Mycobacterium species led to the identification of several ring oxidation products, including pyrene 4,5-dihydrodiol and 4-phenanthroic acid (15). Later studies conducted with other Mycobacterium strains identified phenanthrene 4,5-dicarboxylic acid as another intermediate metabolite (7, 37). Based on these findings, a pathway of pyrene degradation by Mycobacterium species has been proposed which likely involves a dioxygenase for catalysis of the initial attack of the aromatic substrate (6, 7, 20) (Fig. 1). None of the enzymes involved in the catabolism of pyrene has yet been described, except for a polycyclic aromatic ring dioxygenase recently identified in the pyrene-degrading Mycobacterium strain PYR-1 (24). In this study, a Mycobacterium strain selected for its ability to grow with pyrene as the sole carbon and energy source was used to identify proteins involved in pyrene catabolism. For this purpose, proteins from bacteria grown on pyrene and other carbon sources were subjected to metabolic labeling and two-dimensional (2D) electrophoresis. This approach allowed the detection of several pyrene-specific polypeptides, some of which were identified by N-terminal and internal peptide sequencing as putative catabolic enzymes. Two distinct ring-hydroxylating dioxygenases were found to be coexpressed in PAH-grown cells. The genes encoding the two pyrene-induced dioxygenases have been cloned, sequenced, and overexpressed in Escherichia coli.
![]() View larger version (22K): [in a new window] |
FIG. 1. Proposed metabolic pathway for the biodegradation of pyrene and phenanthrene in Mycobacterium species. Steps 1 to 6 are specific to the degradation of pyrene (20), and steps 7 to 15 represent the o-phthalate pathway of phenanthrene degradation, with steps 9 to 15 being common to the degradation pathways of the two PAHs. The genes encoding the enzymes of the phenanthrene degradation pathway, which have been identified in Nocardiodes sp. strain KP7 (16, 17, 34), are shown in italics. The enzyme activities thought to be involved in the catalysis of each step shown are as follows: (1) ring-hydroxylating dioxygenase; (2) dihydrodiol dehydrogenase; (3) intradiol dioxygenase; (4) decarboxylase; (5) ring-hydroxylating dioxygenase; (6) dehydrogenase-decarboxylase; (7) ring-hydroxylating dioxygenase; (8) dihydrodiol dehydrogenase; (9) extradiol dioxygenase; (10) isomerase; (11) hydratase-aldolase; (12) aldehyde dehydrogenase; (13) ring-cleaving dioxygenase; (14) hydratase-aldolase; (15) aldehyde dehydrogenase.
|
|
|
|---|
Bacterial strains, plasmids, and culture conditions. Mycobacterium strain 6PY1 was isolated from PAH-contaminated soil by successive enrichment cultures with pyrene as the sole carbon source, as will be described elsewhere (J. C. Willison, unpublished results). This bacterium was grown on a mineral salts medium (MSM) (40) supplemented with one of the following substrates used as a sole carbon and energy source: acetate (30 mM), benzoate (5 mM), phenanthrene (0.5 g/liter), or pyrene (0.1 g/liter). The latter two substrates were supplied as solutions in silicone oil, so that the ratio of the organic phase to the aqueous phase was 1:5. Growth took place at 25°C in Erlenmeyer flasks incubated in a rotary shaker at 150 rpm. Bacterial density was measured spectrophotometrically as the optical density at 600 nm (OD600).
E. coli strains and plasmids used in this study are listed in Table 1. Strains DH5
and BL21(DE3)(pLysS) or BL21AI were used for general cloning and protein expression, respectively. Culture was carried out on rich broth (Luria-Bertani [LB]) containing appropriate antibiotics.
|
View this table: [in a new window] |
TABLE 1. Bacterial strains and plasmids used
|
Preparation of bacterial protein extracts. Cultures were harvested at 4°C by centrifugation for 15 min at 15,000 x g. Pellets were washed twice in 10 ml of 0.05 M Tris-HCl buffer (pH 7.5) and resuspended in two volumes of sonication buffer (0.1 M Tris-HCl [pH 7.5] containing 0.01 M EDTA). The bacterial suspensions were transferred to 10-ml conical glass tubes and subjected to sonication for 10 min on ice with a Vibra cell ultrasonifier (10% of maximum amplitude; 5-s pulse intervals). The lysate was centrifuged for 10 min at 15,000 x g to remove cell debris and then supplemented with 10 mM spermine (Sigma-Aldrich) and further centrifuged for 20 min at 290,000 x g with an Optima TL ultracentrifuge (Beckman Instruments). The supernatant fraction was then extensively dialyzed against 2 mM phosphate buffer (pH 7.5) in a dialysis cassette with a 10,000-Mr cutoff (Slide-A-Lyser; Pierce). Samples were stored at -20°C until needed.
2D-PAGE. Protein samples were analyzed according to the 2D polyacrylamide gel electrophoresis (2D-PAGE) method described by Görg et al. (11). Samples (250 µg) were adjusted to 9 M urea, 2% (wt/vol) 3-[(3-cholamidopropyl)-dimethylammonio]-1-propanesulfonate (CHAPS), 0.32% (vol/vol) Pharmalytes (pH 3 to 10) or 2% (vol/vol) immobilized pH gradient buffer of the appropriate pH range, 0.02% (wt/vol) bromophenol blue, and 0.15% (wt/vol) dithiothreitol in a total volume of 0.45 ml and then applied to 18-cm dry gel strips carrying an immobilized pH gradient (Amersham Biosciences). Strips were allowed to rehydrate with sample solutions for at least 6 h at room temperature. Linear pH gradient gels in the 4 to 7 range were generally employed, but occasionally a narrower pH gradient in the 4.5 to 5.5 range was used.
Isoelectric focusing was carried out in a Multiphor II electrophoresis unit connected to a Multidrive XL power supply (Amersham Biosciences). Voltage was increased stepwise from 150 to 3,500 V over 5 h and held at this value for at least 12 h, resulting in a minimum of 44,000 V · h. Gel strips were subsequently incubated for 30 min in 5 ml of equilibration buffer (6 M urea, 50 mM Tris-HCl [pH 8.8], 30% glycerol, 1% sodium dodecyl sulfate [SDS], 16 mM dithiothreitol, 0.01% bromophenol blue) and applied on top of a 12.5% polyacrylamide gel. Second-dimension electrophoresis was carried out in a Protean II xi cell (Bio-Rad) at 40 mA for 4 to 5 h by using a standard Tris-glycine buffer system. Occasionally, the second dimension was performed in a Tris-Tricine buffer system (36). The proteins were visualized by silver staining or Coomassie blue staining. Gels were scanned wet with an Agfa scanner (model Duoscan T1200) and subsequently dried between cellophane sheets with an air drier (Easy Breeze gel dryer; Amersham Biosciences).
Determination of N-terminal and internal peptide sequences. For protein sequence analysis of selected spots, 2D gels were loaded with a sample containing between 0.6 and 0.9 mg of protein. After the second dimension, the gel was transferred onto a polyvinylidene difluoride membrane (Problott; Applied Biosystems, Courtaboeuf, France) by semidry electroblotting (30 min at 170 mA) in 10 mM 3-[cyclohexylamino]-1-propanesulfonic buffer (pH 9.5) containing 10% methanol. After protein staining with Coomassie blue, spots of interest were excised from the polyvinylidene difluoride membrane and then subjected to automated Edman degradation on an Applied Biosystems sequencer.
For peptide sequencing by tandem mass spectrometry (MS/MS), protein spots of interest were cut out from Coomassie blue-stained 2D gels and then subjected to in-gel trypsin digestion as previously described (9). Each gel band was then extracted with 5% (vol/vol) formic acid solution and acetonitrile. Extracts were combined and evaporated to dryness. The residues were dissolved in 0.1% (vol/vol) formic acid and desalted with a Zip Tip (Millipore, Bedford, Mass.). Elution of the peptides was performed with 5 µl of a 50:50:0.1 (vol/vol) acetonitrile-H2O-formic acid solution. The peptide solution was introduced into a glass capillary (MDS Protana, Odense, Denmark) for nanoelectrospray ionization. MS/MS experiments were carried out on a quadrupole time of flight hybrid mass spectrometer (Micromass, Manchester, United Kingdom). Collision-induced dissociation of selected precursor ions was performed by using argon as the collision gas and with collision energies of 40 to 60 eV. Interpretation of MS/MS spectra was achieved manually and with the help of the PepSeq program (MassLynx software; Micromass). Data obtained from N-terminal and MS/MS sequence analyses were used for homology searches in the databases with the use of the BLAST facility (http://www.ncbi.nlm.nih.gov/BLAST) or the FASTA program (33).
In vivo 35S-labeling of proteins. Acetate-grown cultures of Mycobacterium were harvested in mid-log phase and resuspended to an OD600 of 2.0 in MSM. Portions of this suspension (25 ml) were transferred to 100-ml flasks containing one of the following carbon sources: pyrene (5 mg), phenanthrene (25 mg), benzoate (5 mM), acetate (25 mM), or none. PAHs were supplied as 5-ml solutions in silicone oil. After 1 h of incubation at 25°C, bacterial suspensions were supplemented with 0.14 mCi (5.18 MBq) of a 35S-labeled mixture of methionine and cysteine (Easytag Express protein-labeling mix; NEN Life Science Products) combined with a mix of the two nonlabeled amino acids as carriers (12 µM Met plus 6 µM Cys). Bacteria were further incubated for variable time periods depending on the carbon source added: 6 h (benzoate and acetate), 17 h (phenanthrene), or 32 h (pyrene and no carbon source added). Then cells were harvested by centrifugation, washed once in MSM, and resuspended in 0.25 ml of 0.1 M Tris-HCl-10 mM EDTA (pH 8.0). Bacterial extracts were prepared as described above and analyzed by 2D-PAGE (375-µg protein samples were used). Gels were stained with Coomassie blue, dried, and exposed to X-ray films for 4 days (Hyperfilm-ßmax; Amersham Biosciences).
General DNA manipulations. Restriction enzyme digestions, ligations, and agarose gel electrophoresis were performed by using standard procedures (35). DNA fragments were purified from agarose gels by using a Jetquick gel extraction spin kit (Genomed GmbH, Bad Oeynhausen, Germany). Mycobacterium DNA was isolated by using the following method adapted from that of Gonzalez-y-Merchand et al. (10). Benzoate-grown cells (from 2.8 liters of culture) were harvested in mid-log phase, resuspended in TE buffer (10 mM Tris-HCl, pH 8.0, containing 1 mM EDTA), and treated with 10 mg of lysozyme/ml at 37°C for 30 min. The suspension was adjusted to 1% SDS and subjected to three freeze-thaw cycles consisting of a freezing step with liquid nitrogen followed by heating at 65°C for 10 min. Cetyltrimethylammonium bromide (11.3 g/liter) was added to facilitate the removal of polysaccharides and proteins during two chloroform-isoamyl alcohol extraction steps. Two more phenol-chloroform-isoamyl alcohol extractions were then performed before the precipitation of nucleic acids with isopropanol. DNA was washed in 70% ethanol and dissolved in TE buffer.
For Southern hybridization experiments, DNA fragments used as probes were labeled with digoxigenin by using a random prime labeling kit (Roche Diagnostics, Meylan, France). Mycobacterium genomic DNA samples (1 to 2 µg) were digested to completion with restriction endonucleases EcoRI, EcoRV, HindIII, BamHI, PstI, and SmaI and then analyzed by electrophoresis on a 1% agarose gel. The DNA fragments were denatured with NaOH and transferred by Southern blotting onto nylon membrane (Biodyne; Pall Life Sciences, Saint-Germain-en-Laye, France). The membrane was prehybridized for 1 h and then hybridized overnight at 65°C. Posthybridization washings and detection were performed according to the protocol of the supplier (Roche Diagnostics).
Construction of a genomic library. Genomic DNA from Mycobacterium sp. strain 6PY1 was digested with restriction enzyme BamHI, and the fragments obtained were cloned into predigested ZAP Express vector according to the supplier's instructions (Stratagene Europe, Amsterdam, The Netherlands). The ligated DNA was packaged by using the Gigapack III gold packaging extract (Stratagene) and propagated as recombinant phages in E. coli XL1-Blue MRF'. Clones of E. coli containing corresponding phagemids were transferred to 96-well microtiter plates to facilitate screening of the library.
Cloning of the genes encoding dioxygenase components Pdo1 and Pdo2 from strain 6PY1.
Two degenerate primers (K7-F, 5'-CARACSGARACSACSGA-3', and ISP
1-R, 5'-CCASCCRTGRTASSWRCA-3') were designed based on the N-terminal sequence of protein P10 and an internal consensus sequence (CSYHGW) found in most dioxygenase
subunits. With these two primers, a 372-bp DNA fragment was amplified by PCR with Mycobacterium DNA as the template. This fragment was cloned into E. coli by using the pCR2.1 cloning kit (Invitrogen), resulting in plasmid pSK-B3, and its sequence was determined. The genes encoding Pdo1 were amplified by PCR by using strain 6PY1 genomic DNA as the template and the Expand High-Fidelity DNA polymerase (Roche Diagnostics). The following primers were employed: pdoA1-F (5'-GGCATATGCAAACGGAAACGACCGA) and pdoA1-R (5'-GGGATATCTCAAGCACGCCCGCCGAATG) for pdoA1 and pdoB1-F (5'-GGCATATGAACGCCGTTGCCGTGGA) and pdoB1-R (5'-GGGGATCCTACAGGACTACCGACAG) for pdoB1 (underlined sequences denote restriction sites for NdeI, EcoRV, and BamHI). Primer pdoA1-F was designed after the 5' end of the 372-bp DNA fragment described above. The other primers were designed after the nucleotide sequences of nidA (accession number AF249301) and nidB (accession number AF249302) from Mycobacterium sp. strain PYR-1. PCR products were ligated into pPCR-Script, giving pSKU03 (pdoA1) and pSKU04 (pdoB1). The DNA sequences of the inserts on both strands were determined. The genes encoding Pdo2 were cloned as follows. A PCR amplification with 6PY1 genomic DNA and two degenerate primers, P3-F (5'-ATGGTNGCNACNGTNGARCA) and P3-R (5'-TCYTCNGCCCANGCRTAYTC), generated a 270-bp fragment which was cloned and sequenced. The same primers were then used to screen the genomic library in ZAP Express by PCR amplification of clones. For this purpose, serial rounds of PCR were carried out on groups of 96, and then of 12, clones, each round consisting of cell lysis by boiling of the colonies in water for 5 min at 95°C, centrifugation, and PCR with 2 µl of supernatant and 10 µl of a mix containing deoxynucleoside triphosphate, primers, and Taq polymerase (Promega). One positive clone was selected, which contained a phagemid with a 2.3-kb insert (pSKU07). The sequence of the insert was determined. A 1.2-kb DNA fragment containing the 3' end of pdoB2 was generated by PCR by using genomic DNA as a template and primers P3-F and Redcons1-R (5'-TTGGAYAGWGGCGGWCGBTCRTAWGG). The first primer corresponds to the 5' end of pdoB2, whereas the second primer was designed after a consensus sequence (PYERPPLSK) found upon alignment of reductase components of representative ring-hydroxylating dioxygenases. The 1.2-kb fragment was cloned into pGEM-T Easy to give pSKU10 and sequenced. DNA sequence analyses as well as protein sequence comparison and alignment were performed by using programs available on the Infobiogen server (http://www.infobiogen.fr/services/deambulum/fr/index.html).
Construction of plasmids for protein overexpression. pdoB1 was isolated from pSKU04 by digestion with NdeI and BamHI and then ligated into pET9a to give pSKU05. This plasmid was digested with XbaI, treated with the Klenow enzyme to generate a blunt-ended product, and further digested with BamHI to generate a 0.6-kb DNA fragment carrying the pdoB1 coding sequence preceded by an efficient ribosome-binding site. This fragment, as well as an NdeI-EcoRV fragment from pSKU03 carrying pdoA1, were ligated between the NdeI and BamHI sites of pET9a to give pSKU06. The resulting plasmid contained the pdoA1 and pdoB1 genes (in that order) located downstream of a T7 promoter, with each gene preceded by a ribosome-binding site sequence optimal for expression in E. coli.
A fragment encompassing the pdoA2B2 gene sequence was amplified as described above by using primers pdoA2-F (5'-GGCATATGTCTACTGTCGGTAAGAA) and pdoB2-R (5'-GGAGATCTTAGAAGAAGTTAGCCAG). The underlined sequences denote NdeI and BglII sites introduced to facilitate subcloning. The PCR product was cloned into pCR-Blunt II-TOPO (Invitrogen) to give pSKU08 and subjected to DNA sequencing to ensure that no error occurred during PCR amplification. The insert of plasmid pSKU08 was isolated by digestion with NdeI and BglII and ligated into pET9a to give pSKU09.
A 1.5-kb DNA fragment carrying the phdC and phdD coding sequences was amplified by PCR by using the Expand High-Fidelity DNA polymerase, plasmid pHA171 as a template, and primers phdCeco (5'-GGAATTCAGGAGATATACATATGCGTGTG) and phdDxba (5'-CTCTAGACTCATGCCGTCGGTAC). The resulting product was treated with an A-addition kit (Qiagen) and cloned into pDRIVE to give plasmid pDRCD. The insert was verified by DNA sequencing and then isolated as an EcoRI-XbaI fragment and cloned into the corresponding sites of pBBR1MCS-5, which gave plasmid pBRCD.
Plasmids pSKU06, pSKU09, and pBRCD were introduced into E. coli strains BL21(DE3)(pLysS) and BL21AI by transformation.
Overexpression and purification of the recombinant Pdo2 dioxygenase component.
E. coli BL21(DE3)(pLysS)(pSKU09) was grown in LB medium containing kanamycin (20 µg/ml) and chloramphenicol (33 µg/ml) to an OD600 of
0.6 and then subjected to induction with 0.1 mM IPTG. After a 3-h incubation at 25°C, the cells were harvested by centrifugation and stored at -20°C until needed. The cells were disrupted by sonication (10% of maximum amplitude; 5-s pulse intervals) for 5 min at 4°C in sonication buffer (50 mM Tris-HCl [pH 7.5], 5 mM EDTA, 5% [vol/vol] ethanol). After centrifugation of the cell extract for 10 min at 10,000 x g, the supernatant fraction was diluted with the same volume of buffer A (50 mM Tris-HCl [pH 7.5], 5% [vol/vol] ethanol, 5% [wt/vol] glycerol) before being applied to a 30-ml DEAE-cellulose column (DE52; Whatman) equilibrated with buffer A. After the column was washed with the same buffer, a brown fraction was eluted with buffer A containing 250 mM NaCl. The brown fraction was adjusted to 1 M ammonium sulfate and applied to a 20-ml phenyl-Sepharose column (Amersham Biosciences). The column was developed with a linear gradient from 1 to 0 M ammonium sulfate in buffer A by using a fast protein liquid chromatography system (Bio-Tek Kontron Instruments, St. Quentin en Yvelines, France). The brown fraction was dialyzed against buffer A and then loaded onto a 1.7-ml column (Optima 5/10 Q-HyperD 10; Biosepra SA, Villeneuve-la-Garenne, France). The column was developed with a linear gradient from 0 to 250 mM NaCl in buffer A. The purified protein was stored frozen in liquid nitrogen.
Overexpression of the Pdo1 component and purification of the
subunit.
Expression of Pdo1 in E. coli BL21(DE3)(pLysS)(pSKU06) was carried out under conditions similar to those described above, except that recombinant cells were induced with 50 µM IPTG at 15°C for 16 h. The cells were disrupted by sonication (same conditions as described above), and the crude extract was centrifuged for 10 min at 10,000 x g to recover the insoluble fraction. This fraction was solubilized in 40 mM Tris-HCl (pH 8.0) containing 8 M urea and then centrifuged for 10 min at 10,000 x g. This sample was diluted by half in H2O and applied to a 20-ml column of DEAE-Trisacryl LS (Biosepra SA) equilibrated with 20 mM Tris-HCl (pH 8.0) containing 4 M urea (buffer B). The column was developed with a linear gradient from 0 to 0.5 M NaCl in buffer B. Fractions containing a prominent 52-kDa band were pooled and concentrated. The 52-kDa protein was further purified by preparative SDS-PAGE and then eluted from gel slices by using an electroeluter (model 422; Bio-Rad SA). The purified preparation was used to raise rabbit polyclonal antibodies against the Pdo1
subunit, according to the standard protocol of the supplier (Eurogentec). Antibodies against the Pdo2
subunit were obtained under similar conditions.
In vivo assays of recombinant Pdo1 and Pdo2 activity. The PAH dioxygenase activity of recombinant E. coli cells expressing Pdo1 or Pdo2 was assayed as follows. Cells were grown in LB medium to an OD600 of 1.0 and then incubated overnight at 25°C with 0.5 mM IPTG and/or 0.2% DL-arabinose, depending on the strain. Cells were harvested, resuspended in the same volume of M9 minimal medium, and incubated with one-fourth (by volume) of the silicone oil containing 0.1 g of either pyrene or phenanthrene/liter. At various time intervals, samples (0.5 to 1.0 ml) of the upper layer emulsion were withdrawn and briefly centrifuged. The oil phase was extracted with acetonitrile, and the absorbance of the extract was recorded in the 200-to-350 nm range. Amounts of residual pyrene and phenanthrene were calculated from absorption readings at 240 and 252 nm, respectively. Hydrosoluble products were analyzed in 5-ml samples of the aqueous phase, which were centrifuged and then passed through solid-phase extraction columns (Upti-clean C18U, 0.5 g; Interchim, Montluçon, France). Columns were washed with 10 ml of water and then eluted with 1 ml of methanol. Extracts were evaporated under vacuum conditions and stored dry until ready to be analyzed by gas chromatography (GC)-MS. Prior to analysis, extracts were derivatized either with bis(trimethysilyl)trifluoroacetamide:trimethylchlorosilane (99:1) or with n-butylboronate (NBB), both reagents from Supelco (Sigma-Aldrich), according to the manufacturer's instructions. GC-MS analysis was carried out on a HP6890/HP5973 apparatus (Agilent Technologies, Les Ulis, France) equipped with an MDN-12 fused silica capillary column (30 m, 0.25-mm internal diameter, 0.25-µm film; Supelco). The oven temperature was held at 75°C for 3 min and then increased to 250°C at 12°C/min, held at this temperature for 1 min, and then increased to 300°C at 10°C/min, with a final hold time of 10 min. The injector was used in the split mode, with a split ratio of 50:1 and an injection volume of 2.5 µl. Mass detection was carried out in the selected ion monitoring mode for quantification and in the total ion current mode for determination of the mass spectra of diols and their derivatives. The solvent delay prior to data acquisition was 5.5 min for trimethylsilyl (TMS) derivatives and 11 min for NBB derivatives.
The TMS derivatives of phenanthrene and pyrene dihydrodiols were quantified by using purified phenanthrene cis-9,10-dihydrodiol and pyrene cis-4,5-dihydrodiol as standards (Willison, unpublished). GC-MS peak areas were proportional to sample concentration when the selected ion monitoring mode of detection was used, with the selected ions having m/z values of 290 for the TMS derivative of pyrene dihydrodiol and 178, 266, and 356 for the TMS derivative of phenanthrene dihydrodiol. Phenanthrene cis-3,4-dihydrodiol was provisionally identified on the basis of the mass spectra of the underivatized and derivatized compounds and its longer GC retention time with respect to the 9,10-isomer (32).
Other analytical methods. Whole-cell protein content was determined according to the method of Lowry et al. (29) after bacterial samples were subjected to 0.2 M NaOH for 1 h at 90°C. Routine protein assays were done with the bicinchoninic acid reagent kit (Pierce) by using bovine serum albumin as a standard. SDS-PAGE on mini slab gels and Western blot analysis were performed as previously described (18). Rabbit serum antibodies and secondary goat anti-rabbit immunoglobulin G coupled to peroxidase (Sigma-Aldrich) were used at a 1:5,000 dilution.
Nucleotide sequence accession numbers. The nucleotide sequences described in this report have been deposited in the DDBJ, EMBL, and GenBank databases under accession numbers AJ494743, AJ494744, and AJ494745.
|
|
|---|
![]() View larger version (19K): [in a new window] |
FIG. 2. Time course of [14C]pyrene mineralization by Mycobacterium strain 6PY1 grown on different C sources. Bacteria were incubated with [14C]pyrene in closed flasks as described in Materials and Methods. The 14CO2 that evolved was continuously trapped in sodium hydroxide and quantified at the times indicated. Results shown are the means of results from duplicate experiments and are expressed as the amount of cumulated pyrene mineralization normalized to the protein concentration of the bacterial samples. Bacteria were grown on either pyrene ( ), phenanthrene (), benzoate ( ), or acetate ( ). Acetate-grown cells were also incubated with chloramphenicol ( ). The extent of pyrene mineralization at the end of the experiment was 38.9, 44.5, 17.8, and 17.2% for cells grown on pyrene, phenanthrene, benzoate, and acetate, respectively.
|
subunit (Pdo2
; see below), appeared as a minor peptide found very close to the triplet of spots generated by P21 (Fig. 3B). P20 was unambiguously identified as the
subunit of Pdo2 upon 2D-PAGE analysis of a 6PY1 extract from pyrene-grown cells supplemented with purified Pdo2 (Fig. 3C). At this stage of our comparative 2D-PAGE analysis, a total of 16 distinct polypeptides appeared to be specifically synthesized in pyrene-grown cells of strain 6PY1 (Fig. 3). Most of the selected polypeptides were also found in phenanthrene-grown cells, but five proteins were missing in benzoate-grown cells (designated P4, P5, P8, P14, and P20).
![]() View larger version (66K): [in a new window] |
FIG. 3. 2D-PAGE analysis of the soluble extract from strain 6PY1 grown on pyrene. (A) Proteins were separated in a pI gradient from 4 to 7 and then on a 12.5% polyacrylamide gel, after which they were silver stained. The pI and molecular mass (in kilodaltons) ranges are indicated. (B) Enlargement of the boxed area indicated in panel A. (C) Same area of a gel loaded with a similar extract supplemented with purified Pdo2. Polypeptides that were absent in acetate-grown cells are indicated by arrows and numbered as a function of increasing Mrs. Polypeptides P1, P3, P7, P10, P16, P17, and P19 do not sppear in this figure.
|
![]() View larger version (75K): [in a new window] |
FIG. 4. 2D-PAGE analysis of 35S-labeled proteins induced upon incubation of strain 6PY1 with pyrene or other carbon sources. Acetate-grown cells were incubated with either pyrene, phenanthrene, benzoate, or acetate in the presence of 35S-labeled amino acids as described in Materials and Methods. Labeled proteins were then analyzed by 2D-PAGE and autoradiography. Boxed protein spots were not detected in control cells incubated with no carbon source or with acetate. Proteins P21 and P6 represent the and ß subunits of Pdo1, and P20 and P8 represent the and ß subunits of Pdo2.
|
subunit of benzene dioxygenase and the nidA gene product from strain PYR-1. Gene sequencing later revealed that protein P21 was associated with protein P6 to form a ring-hydroxlating dioxygenase (see below). |
View this table: [in a new window] |
TABLE 2. Sequence analysis of pyrene-induced polypeptides from 6PY1 and possible functions based on sequence similarities
|
Further comparison of 2D gel patterns revealed that four polypeptides found in extracts from phenanthrene-grown cells were either absent or much less abundant under other culture conditions (data not shown). The N-terminal sequences of those peptides were determined. Searches in the databases yielded a significant match for only one polypeptide, called P23, whose N terminus displayed 60% identity with that of a dihydrodiol dehydrogenase (BphB; accession number D88021) from the biphenyl-degrading strain Rhodococcus erythropolis TA421 (25). A 50% sequence identity was also found between the P23 N terminus and that of the phdE gene product, another dihydrodiol dehydrogenase thought to be involved in phenanthrene degradation in Nocardioides strain KP7 (34). The apparent molecular characteristics of protein P23 (Mr, 27,000; pI 5.15) are also consistent with those of many dihydrodiol dehydrogenases, including PhdE (mass, 28,150 Da; pI 5.1).
Cloning and nucleotide sequence analysis of the genes encoding two distinct arene dioxygenases.
In order to clone the gene encoding protein P21, a DNA fragment was amplified by PCR from the genomic DNA of Mycobacterium strain 6PY1 by using two primers designed from the N terminus of P21 and a consensus sequence (C[P/S]YHGW) found at the iron-sulfur binding site in dioxygenase
subunits. The resulting 372-bp fragment was sequenced and found to be 98% identical to the 5' end of the nidA gene from Mycobacterium sp. strain PYR-1 (24). Since protein P6 had an N-terminal sequence closely similar to that of the nidB gene product from strain PYR-1, it was likely that proteins P21 and P6 were encoded by genes homologous to the nid genes from strain PYR-1. We then used two sets of primers designed after the 5' and 3' ends of nidA and nidB, respectively, and performed PCR amplification with strain 6PY1 DNA as a template. Two fragments were obtained, cloned, and sequenced. One fragment consisted of a 1,377-bp open reading frame (ORF), potentially coding for a 50,336-Da polypeptide. The second fragment comprised 512 bp and might encode a polypeptide with a predicted molecular mass of 19,502 Da. The N termini of the deduced polypeptides exactly matched those found for proteins P6 and P21. These genes displayed high similarity with the nidB and nidA genes from strain PYR-1, and further PCR analysis suggested that they were arranged in the same atypical order, i.e., nidB preceded nidA (Fig. 5). Unlike the nidBA genes from strain PYR-1, the corresponding genes from strain 6PY1 are not inducible by naphthalene, since this strain cannot use this PAH as a growth substrate. They were therefore designated pdoB1(ß subunit) and pdoA1(
subunit).
![]() View larger version (17K): [in a new window] |
FIG. 5. Maps representing the two loci containing the dioxygenase-encoding genes from Mycobacterium sp. strain 6PY1. Plasmids used for overexpression of pdoA1B1 (A) and pdoA2B2 (B) in E. coli are also represented. Black squares indicate ribosome-binding sequences optimal for E. coli. B, BamHI.
|
library constructed with strain 6PY1 genomic DNA. A positive clone that carried a 2.3-kb insert was isolated. Sequence analysis revealed that the insert contained two partial ORFs and one complete ORF (Fig. 5). The first ORF (partial sequence) translated into a polypeptide sequence of 189 residues which exhibited 88% identity with an extradiol dioxygenase from Nocardioides strain KP7 (phdF gene product) (34). The second ORF comprised 1,401 bp and translated into a 466-residue polypeptide which showed strong similarity with the
subunit of the phenanthrene dioxygenase from strain KP7 (phdA gene product; 73% identity) (34). The sequence of the third ORF, which encodes protein P8, was interrupted at the 3' end of the insert at a BamHI site. A DNA fragment starting at the 5' end of this ORF and extending 1.2 kb downstream was generated by PCR and subjected to sequencing. Thereby, the complete sequence of the gene encoding protein P8 was determined. The deduced polypeptide sequence showed 63% identity with the product of phdB which codes for the ß subunit of phenanthrene dioxygenase in strain KP7. Hence, a second dioxygenase system was identified in strain 6PY1, encoded by genes designated pdoA2 and pdoB2. Downstream of pdoB2, we found an ORF similar in sequence and location to ORF72 in strain KP7. Further downstream, no sequence analogous to a gene present in the phd operon of strain KP7 could be identified. In this respect, we were unable to detect a reductase-encoding gene analogous to phdD (found 3 kb downstream from phdB in strain KP7) by employing several PCR-based strategies in attempts to amplify such a gene downstream of pdoB2 (data not shown). For instance, a PCR product was obtained by using primers designed to hybridize to pdoB2 and to a consensus sequence found in several reductases, including PhdD (see Materials and Methods), but surprisingly, no sequence relevant to a reductase was found in this fragment (Fig. 5). Also, attempts were made to detect a potential ferredoxin or reductase gene by subjecting total DNA to Southern hybridization with the phdC or phdD gene from KP7 as probes, but no specific signal was obtained. Hence, there was no evidence for a gene coding for a ferredoxin or a reductase in the immediate vicinity of pdoA2B2. Digestions of total genomic DNA from strain 6PY1 with six restriction enzymes were analyzed by Southern hybridization by using probes specific for pdoA1 or pdoA2. Results showed a single-band pattern in every case (data not shown), indicating that each gene was present as a single copy in the genome and that the probes did not detect an additional homologous gene under the conditions used.
Overexpression and purification of the terminal component of two dioxygenases from strain 6PY1.
To further characterize the two dioxygenase systems found in strain 6PY1, the pdoA1B1 and pdoA2B2 pairs of genes were separately cloned in expression vector pET9a and overexpressed in E. coli BL21(DE3)(pLysS), as described in Materials and Methods. Analysis of crude extracts of IPTG-induced recombinant cells by SDS-PAGE revealed that two polypeptides with Mrs of about 52,000 and 20,000 were overproduced in both cases (data not shown). Parts of the recombinant polypeptides were pelleted with cell debris upon centrifugation of broken cells, indicating that they formed insoluble inclusion bodies in E. coli. When strain BL21AI was used as a host, a greater proportion of the recombinant Pdo1 and Pdo2 proteins was recovered in the soluble fraction, which correlated with the detection of much higher levels of dioxygenase activity in those recombinant cells (see below). The Pdo2 protein could be purified to near homogeneity by using a three-step procedure (see Materials and Methods). The Pdo1 protein appeared to be unstable and lost its brown color at the second step of the purification. Nevertheless, the
subunit of this protein could be purified under denaturing conditions and was used to raise antibodies for immunoblot studies (see below).
The purified Pdo2 enzyme, encoded by pdoA2B2, consisted of two types of subunits, with Mrs of 52,000 (
subunit) and 20,000 (ß subunit) in accordance with the expected sizes of the pdoA2 (51.7 kDa) and pdoB2 (19.8 kDa) gene products, respectively (Fig. 6). It appeared as a red-brown protein fraction which displayed a broad absorption band in the visible range, with a maximum around 456 nm. The absorption coefficient at 456 nm was calculated to be 10.6 mM-1 · cm-1, assuming a molecular mass of 215 kDa for an expected
3ß3 hexamer. This value is similar to the values previously reported for the terminal component of other dioxygenases (8, 13). These data are consistent with the presence of one Rieske-type (2Fe-2S) cluster per pair of
ß subunits in the recombinant protein.
![]() View larger version (90K): [in a new window] |
FIG. 6. SDS-PAGE analysis of recombinant Pdo2 during purification from E. coli. Lane 1, crude extract; lane 2, soluble fraction; lane 3, DEAE column eluate; lane 4, phenyl-Sepharose column eluate; lane 5, Q-HyperD column eluate; lane M, protein markers. Arrows show the positions of the Pdo2 and ß subunits.
|
![]() View larger version (16K): [in a new window] |
FIG. 7. Phenanthrene transformation by recombinant strains of E. coli overproducing Pdo2. (A) Mass spectrum and proposed structure of the major oxidation product, phenanthrene cis-3,4-dihydrodiol, recovered from a culture of strain BL21AI(pSKU09) incubated with phenanthrene. The diol product was derivatized with NBB. (B) Time course of phenanthrene transformation by strain BL21AI(pSKU09)(pBRCD) coexpressing pdoA2B2 and phdCD.
|
|
View this table: [in a new window] |
TABLE 3. Production of pyrene and phenanthrene dihydrodiols by E. coli strains overproducing the two dioxygenases from Mycobacterium sp. strain 6PY1a
|
Differential expression of the two dioxygenases in strain 6PY1.
Polyclonal antibodies were raised against the purified large subunits of Pdo1 and Pdo2 and used to detect the presence of each dioxygenase in cell extracts from strain 6PY1. Control immunoblot analysis revealed that the Pdo2 large subunit cross-reacted with the anti-Pdo1
antibodies but that the Pdo1 subunit did not cross-react with anti-Pdo2
. Western blot analysis of strain 6PY1 cell protein extracts prepared from cultures grown with four different C sources indicated that Pdo1 was produced provided that bacteria were supplied with an aromatic compound but that it was undetectable in acetate-grown cells (Fig. 8A). In addition, a faint band that had the same mobility as Pdo2
was detected in the pyrene and phenanthrene extracts. Analysis of the same protein extracts with anti-Pdo2
antibodies revealed that the Pdo2 enzyme was detectable only in PAH-grown cells (Fig. 8B). These findings indicated that Pdo1 synthesis was induced by a single-ring aromatic compound or a PAH but that the Pdo2 biosynthesis required the presence of a PAH. This result is consistent with the results of 2D gel analyses, showing that Pdo1 was detectable in cells induced with each of the three aromatic substrates but that Pdo2 was detectable only in PAH-induced cells (Fig. 4).
![]() View larger version (60K): [in a new window] |
FIG. 8. Immunoblot detection of Pdo1 and Pdo2 in cell extracts of strain 6PY1. Lanes were loaded with the same amounts of cell proteins prepared from bacteria grown on acetate (lane 1), benzoate (lane 2), phenanthrene (lane 3), and pyrene (lane 4). After separation by SDS-PAGE and electrotransfer onto nitrocellulose, proteins were immunodetected by using either anti-Pdo1 (A) or anti-Pdo2 (B) polyclonal antibodies. Lane 5 was loaded with 0.4 µg of Pdo2.
|
|
|
|---|
The second step would be catalyzed by a dihydrodiol dehydrogenase. An enzyme of such type was detected in phenanthrene-grown cells, but we do not know whether this enzyme is also present in pyrene-grown cells and whether it could use pyrene 4,5-dihydrodiol as a substrate. The next three steps, involving ortho cleavage of 4,5-dihydroxypyrene, decarboxylation of 4,5-phenanthrene dicarboxylic acid, and dihydroxylation of 4-phenanthroic acid, are catalyzed by unknown enzymes. Perhaps components of such enzymes might be found among the pyrene-specific polypeptides which remain to be identified (Fig. 3 and 4; Table 2). Alternatively, we might have failed to detect some of these enzymes due to limitations of the approach employed based on 2D-PAGE analysis. Especially, proteins of interest could have passed undetected if they were membrane bound or synthesized at very low levels. This is probably the case for the reductase and the ferredoxin, which are expected to associate with the Pdo1 and Pdo2 terminal components to form active dioxygenase complexes.
The present study demonstrates that the biosynthesis of the catabolic enzymes responsible for PAH degradation in strain 6PY1 is under strict metabolic control. In acetate-grown cells, no pyrene mineralization activity was detected and many proteins identified as PAH catabolic enzymes were absent. Likewise, pyrene degradation enzymes were found to be inducible in Mycobacterium strain PYR-1 (14). Several enzymes involved in PAH degradation, including Pdo1 and proteins which appear to be specific to the catabolism of phenanthrene (proteins P13, P15, P18, and P22), were biosynthesized at high levels in benzoate-grown cells (Fig. 4D). This result suggested that the synthesis of these enzymes is induced by a metabolite formed upon degradation of aromatic hydrocarbons rather than by PAHs. A few polypeptides, including the two subunits of Pdo2, were synthesized only in the presence of a PAH, indicating that they are subjected to a regulation mechanism different from that controlling the enzymes induced by benzoate. Finally, we observed that some polypeptides were detectable only in pyrene-induced cells and that other proteins, including a dihydrodiol dehydrogenase, were found exclusively or predominantly in phenanthrene-grown cells. Hence, the synthesis of PAH catabolic enzymes appears to involve several regulatory mechanisms which remain to be elucidated in future studies.
The two dioxygenase terminal components described herein were found to be related to enzymes found in four actinomycete species, including two Rhodococcus strains (27, 38), Nocardioides strain KP7 (34), and Mycobacterium strain PYR-1 (24). In previous reports, phylogenetic analysis indicated that these dioxygenases formed a cluster of enzymes distinct from other dioxygenases (24, 34). Hence, the Pdo1 and Pdo2 enzymes from strain 6PY1 are two new members of the same phylogenetic group. As judged from in vivo activity assays, the two dioxygenases showed markedly different selectivities towards pyrene and phenanthrene. Pdo1 converted pyrene to pyrene cis-4,5-dihydrodiol much more efficiently than did Pdo2, whereas the latter enzyme displayed higher activity in the oxidation of phenanthrene. It might be inferred that in strain 6PY1 the initial attack of each PAH substrate involved a specialized enzyme, Pdo1 for pyrene and Pdo2 for phenanthrene. Interestingly, the dioxygenase most similar to Pdo1 was shown to oxidize pyrene (24), whereas the enzyme with closest similarity to Pdo2 was described as a phenanthrene dioxygenase (34). The Pdo2-catalyzed oxidation of phenanthrene yielded almost exclusively the 3,4-dihydrodiol, which is the natural substrate of the cis-dihydrodiol dehydrogenase, consistent with the current pathway of phenanthrene degradation (Fig. 1). Pdo1 also generated 9,10-dihydroxyphenanthrene, which is probably not metabolized further. This metabolite, but not the 3,4-dihydrodiol, was detected in the culture medium of strain 6PY1 growing on phenanthrene (unpublished results), indicating that it is probably formed as a dead-end product, mainly as a result of Pdo1 activity.
As for other ring-hydroxylating dioxygenases, Pdo1 and Pdo2 certainly require electron carrier proteins for catalysis, namely an NAD(P)H reductase and a ferredoxin. Since those recombinant enzymes showed detectable activity in vivo, electron carriers from E. coli certainly replace at least partially the dioxygenase-specific electron carriers. Likewise, the terminal dioxygenase components from Burkholderia sp. strain RP007 (28), Pseudomonas abietaniphila BKME-9 (30), Rhodococcus sp. strain 19070 (12), and Terrabacter sp. strain DBF63 (23) were found to be active in E. coli with the complementation of nonspecific ferredoxin and reductase components from the host. On the other hand, the dioxin dioxygenase from Sphingomonas sp. strain RW1 was active in E. coli only when the appropriate electron carrier proteins were simultaneously expressed (1). As for the two dioxygenase components described in this study, the source of reductant provided by E. coli was probably suboptimal, as judged from the stimulation of Pdo2 catalytic activity observed in the recombinant strain coexpressing the PhdC and PhdD electron carriers from strain KP7. Further characterization of the Pdo1 and Pdo2 enzymes from strain 6PY1 will require identification of their cognate electron carrier proteins.
This work was supported in part by a grant from the Agence de l'Environnement et de la Maîtrise de l'Energie and by grants from the Centre National de la Recherche Scientifique and the Commissariat à l'Energie Atomique.
|
|
|---|
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»